- BI, Eli Lilly announce academic research collaboration
- Novavax begins Ph 1/2 trial of COVID-19 vaccine
- Daiichi Sankyo launches novel oncology medicine in Japan
- HKBU works on eliminating drug side effects
- Penta Security expands presence in Singapore healthcare sector
- Vaxine announces COVID-19 vaccine collaboration with Medytox
- MIMS conducts COVID-19 conversation web-series for Asian PCPs
- Next-Gen Analytical Software Strengthens Data Exploration
- Seoul hosts "Cities Against COVID-19" Global Summit 2020
- BIO Asia–Taiwan 2020 Online + Live : Finding Cures in the Crisis
- Vayyar, Meditemi to create robot for COVID-19 screening
- Fujifilm to use AI-based technology for COVID-19 diagnosis
- Australian firm Mayne Pharma launches migraine drug in US
- HKBU invents nanostructure for Parkinson's treatment
-
World | 20 March 2020 | Influencers
Eppendorf is investing disproportionately in expansion of its global locations, particularly in Asia
Congratulations on your new role. What are the main agendas behind the recently announced dual leadership at E...Read more
-
World | 27 May 2020 | News
BI, Eli Lilly announce academic research collaboration
Boehringer Ingelheim and Eli Lilly and Company have announced an academic research collaboration with the Duke...Read more
-
China | 27 May 2020 | News
HKBU works on eliminating drug side effects
Scientists from Hong Kong Baptist University (HKBU) have developed a novel technique that can p...Read more
-
World | 05 March 2020 | News
FDA bans ESDs for self injurious behaviour
After careful consideration, the U.S. Food and Drug Administration (FDA) has published a final rule to ban ele...Read more
-
Europe | 06 March 2020 | News
Viroclinics Biosciences and DDL Diagnostic Lab join forces
Netherlands based Viroclinics Biosciences, a leading virology contract research organization, has announced th...Read more
Taiwan’s success story in combating COVID-19
COVID-19 has unravelled the potency and the feebleness of most geographical region’s healthcare, technical, social and political structure. While countries are anticipating various dimensions to tackle coronavirus and combat the pandemic, Taiwan’s success in controlling COVID-19 has bolstered its global standing despite the close geographical proximity with China. The resilient island aggregated its forces to tackle the virus and circumstances rationally with well-established pandemic control strategies, bio medical assets, advanced IoT capabilities, impeccable healthcare system and a well organised political force. Taiwan apparently grappled the coronavirus incredibly well and is now keen to offer medical and technical assistance to other countries in this global crisis.
